Extracorporeal Membrane Oxygenation Machines Market by Modality, Product, and Geography - Forecast and Analysis 2023-2027

Published: Dec 2022 Pages: 167 SKU: IRTNTR40185

Extracorporeal Membrane Oxygenation Machines Market by Modality, Product and Geography - Forecast 2023-2027

The extracorporeal membrane oxygenation machines market size is forecast to increase by USD 243.6 million between 2022 and 2027, accelerating at a CAGR of 10.05%. In 2017, the US held the largest market share, projecting an annual revenue of USD 39.63 million. The report offers extensive research analysis on the Extracorporeal Membrane Oxygenation Machines Market, with a categorization based on modality, including veno-venous, arterio-venous, and veno-arterial. It further segments the market by Product, encompassing ECMO machines and Softwares. Additionally, the report provides geographical segmentation, covering North America, Europe, Asia, and Rest of World (ROW). Market size, historical data (2017-2021), and future projections are presented in terms of value (in USD million) for all the mentioned segments.

What will be the Size of the Extracorporeal Membrane Oxygenation Machines Market During the Forecast Period?

To learn more about this report, Download Report Sample

Extracorporeal Membrane Oxygenation Machines Market Analysis 

The increasing incidence of respiratory and heart failure is notably driving the market growth. The increasing prevalence of various chronic cardiovascular diseases (CVD) and respiratory diseases leads to a rise in the number of deaths. Patients with chronic CVD and respiratory diseases have a high risk of developing respiratory or cardiac failure. Extracorporeal membrane oxygenation machines are used as life-support devices or machines for the treatment of patients with chronic cardiovascular and respiratory diseases. 

The prevalence of CVDs and other heart diseases has increased significantly across the world. Ischemic heart disease, coronary artery disease, and myocardial infarctions are some of the major heart diseases that affect the population. Extracorporeal membrane oxygenation machines minimize the chances of cardiac failure in people with chronic cardiovascular disease. This is expected to fuel the growth of the global extracorporeal membrane oxygenation machines market during the forecast period.

Extracorporeal Membrane Oxygenation Machines Market Segment Trends

Veno-venous is the Leading Segment to Dominate the Market

The veno-venous segment showed a gradual increase in the market share of USD 194.24 million in 2017 and continued to grow by 2021. The increasing prevalence of various chronic respiratory diseases, high incidence of respiratory failures, the growing cases of lung transplants, and increasing technological advances are the major factors contributing to the growth of the veno-venous and arterio-venous extracorporeal membrane oxygenation machines segment of the global extracorporeal membrane oxygenation machines market.

Extracorporeal Membrane Oxygenation Machines Market  - Revenue Share by Modality Segment, 2017-2027.   

For more details on other segments, Download Sample Report 

North America Holds a Prominent Position in the Extracorporeal Membrane Oxygenation Machines Market

North America is estimated to contribute 37% to the growth of the global market during the forecast period. The growth of the market in the region is mainly driven by the increasing prevalence of cardiovascular and respiratory diseases, the increasing number of lung and heart transplant procedures, the rising adoption of technologically advanced medical devices, increasing awareness among healthcare professionals about the benefits of the extracorporeal membrane oxygenation process, and increasing healthcare expenditure. In addition, the growing presence of vendors that manufacture extracorporeal membrane oxygenation machines and increasing technological advances in extracorporeal membrane oxygenation procedures are driving the growth of the market in North America.

Extracorporeal Membrane Oxygenation Machines Market Size, By Region, Global, 2017 - 2027.   

To understand geographic trends Download Report Sample

 Extracorporeal Membrane Oxygenation Machines Market Companies Overview

The Extracorporeal Membrane Oxygenation Machines Market is fragmented in nature. Some significant players include Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd and CytoSorbents Europe GmbH.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG

Segment Overview

The extracorporeal membrane oxygenation machines market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2027.   

  • Modality Outlook (USD Million, 2017 - 2027)
    • Veno-venous
    • Arterio-venous
    • Veno-arterial
  • Product Outlook (USD Million, 2017 - 2027)
    • ECMO machines
    • Software
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The US
      • Canada
    • Europe
      • The UK
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World
      • UAE
      • South Africa

Extracorporeal Membrane Oxygenation Machines Market Scope

Report Coverage

Details

Page number

167

Base year

2022

Historic period

2017 - 2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 10.05%

Market growth 2023-2027

USD 243.6 million

Market structure

Fragmented

YoY growth 2022-2023(%)

8.24

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Abiomed Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Europe GmbH, Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, MC3 Cardiopulmonary, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Palex Medical SA, Sechrist Industries Inc., Senko Medical Industry Co. Ltd., Spectrum Medical Ltd., Terumo Corp., and Xenios AG

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Extracorporeal Membrane Oxygenation Machines Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Modality
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global extracorporeal membrane oxygenation machines market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global extracorporeal membrane oxygenation machines market 2017 - 2021 ($ million)
    • 4.2 Modality Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Modality Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Modality

    • 6.1 Market segments
      • Exhibit 30: Chart on Modality - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Modality - Market share 2022-2027 (%)
    • 6.2 Comparison by Modality
      • Exhibit 32: Chart on Comparison by Modality
      • Exhibit 33: Data Table on Comparison by Modality
    • 6.3 Veno-venous and arterio-venous - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Veno-venous and arterio-venous - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2022-2027 (%)
    • 6.4 Veno-arterial - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Veno-arterial - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Veno-arterial - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Veno-arterial - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Veno-arterial - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Modality
      • Exhibit 42: Market opportunity by Modality ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 43: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 45: Chart on Comparison by Product
      • Exhibit 46: Data Table on Comparison by Product
    • 7.3 ECMO machines - Market size and forecast 2022-2027
      • Exhibit 47: Chart on ECMO machines - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on ECMO machines - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on ECMO machines - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on ECMO machines - Year-over-year growth 2022-2027 (%)
    • 7.4 Softwares - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Softwares - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Softwares - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Softwares - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Softwares - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Product
      • Exhibit 55: Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 57: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 59: Chart on Geographic comparison
      • Exhibit 60: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 Canada - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 97: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 98: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 100: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 101: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 102: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 103: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 104: Abbott Laboratories - Overview
              • Exhibit 105: Abbott Laboratories - Business segments
              • Exhibit 106: Abbott Laboratories - Key news
              • Exhibit 107: Abbott Laboratories - Key offerings
              • Exhibit 108: Abbott Laboratories - Segment focus
            • 12.4 Braile Biomedica
              • Exhibit 109: Braile Biomedica - Overview
              • Exhibit 110: Braile Biomedica - Product / Service
              • Exhibit 111: Braile Biomedica - Key offerings
            • 12.5 Chalice Medical Ltd.
              • Exhibit 112: Chalice Medical Ltd. - Overview
              • Exhibit 113: Chalice Medical Ltd. - Product / Service
              • Exhibit 114: Chalice Medical Ltd. - Key offerings
            • 12.6 Eurosets Srl
              • Exhibit 115: Eurosets Srl - Overview
              • Exhibit 116: Eurosets Srl - Product / Service
              • Exhibit 117: Eurosets Srl - Key offerings
            • 12.7 Fresenius Medical Care AG and Co. KGaA
              • Exhibit 118: Fresenius Medical Care AG and Co. KGaA - Overview
              • Exhibit 119: Fresenius Medical Care AG and Co. KGaA - Business segments
              • Exhibit 120: Fresenius Medical Care AG and Co. KGaA - Key news
              • Exhibit 121: Fresenius Medical Care AG and Co. KGaA - Key offerings
              • Exhibit 122: Fresenius Medical Care AG and Co. KGaA - Segment focus
            • 12.8 Getinge AB
              • Exhibit 123: Getinge AB - Overview
              • Exhibit 124: Getinge AB - Business segments
              • Exhibit 125: Getinge AB - Key news
              • Exhibit 126: Getinge AB - Key offerings
              • Exhibit 127: Getinge AB - Segment focus
            • 12.9 LivaNova Plc
              • Exhibit 128: LivaNova Plc - Overview
              • Exhibit 129: LivaNova Plc - Business segments
              • Exhibit 130: LivaNova Plc - Key offerings
              • Exhibit 131: LivaNova Plc - Segment focus
            • 12.10 MC3 Cardiopulmonary
              • Exhibit 132: MC3 Cardiopulmonary - Overview
              • Exhibit 133: MC3 Cardiopulmonary - Product / Service
              • Exhibit 134: MC3 Cardiopulmonary - Key offerings
            • 12.11 Medtronic Plc
              • Exhibit 135: Medtronic Plc - Overview
              • Exhibit 136: Medtronic Plc - Business segments
              • Exhibit 137: Medtronic Plc - Key news
              • Exhibit 138: Medtronic Plc - Key offerings
              • Exhibit 139: Medtronic Plc - Segment focus
            • 12.12 MicroPort Scientific Corp.
              • Exhibit 140: MicroPort Scientific Corp. - Overview
              • Exhibit 141: MicroPort Scientific Corp. - Business segments
              • Exhibit 142: MicroPort Scientific Corp. - Key offerings
              • Exhibit 143: MicroPort Scientific Corp. - Segment focus
            • 12.13 Nipro Corp.
              • Exhibit 144: Nipro Corp. - Overview
              • Exhibit 145: Nipro Corp. - Business segments
              • Exhibit 146: Nipro Corp. - Key offerings
              • Exhibit 147: Nipro Corp. - Segment focus
            • 12.14 OriGen Biomedical Inc.
              • Exhibit 148: OriGen Biomedical Inc. - Overview
              • Exhibit 149: OriGen Biomedical Inc. - Product / Service
              • Exhibit 150: OriGen Biomedical Inc. - Key offerings
            • 12.15 Sechrist Industries Inc.
              • Exhibit 151: Sechrist Industries Inc. - Overview
              • Exhibit 152: Sechrist Industries Inc. - Product / Service
              • Exhibit 153: Sechrist Industries Inc. - Key offerings
            • 12.16 Terumo Corp.
              • Exhibit 154: Terumo Corp. - Overview
              • Exhibit 155: Terumo Corp. - Business segments
              • Exhibit 156: Terumo Corp. - Key news
              • Exhibit 157: Terumo Corp. - Key offerings
              • Exhibit 158: Terumo Corp. - Segment focus
            • 12.17 Xenios AG
              • Exhibit 159: Xenios AG - Overview
              • Exhibit 160: Xenios AG - Product / Service
              • Exhibit 161: Xenios AG - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 162: Inclusions checklist
                • Exhibit 163: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 164: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 165: Research methodology
                • Exhibit 166: Validation techniques employed for market sizing
                • Exhibit 167: Information sources
              • 13.5 List of abbreviations
                • Exhibit 168: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              extracorporeal membrane oxygenation machines market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis